Similar Articles
Efficacy of coronavirus disease 2019 vaccines in patients with rheumatic diseases
Fatih Taştekin, Meltem Taşbakan, Candan Çiçek, Mehmet Soylu, Figen Yargucu Zihni
DOI: 10.46497/ArchRheumatol.2023.9676
Risk of tuberculosis in children with rheumatologic diseases treated with biological agents: A cross-sectional cohort study
Nuri Bayram, Özge Altuğ Gücenmez, Balahan Makay, Elif Kıymet, Elif Böncüoğlu, Şahika Şahinkaya, Yelda Sorguç, Aybüke Akaslan Kara, Kamile Ötiken Arıkan, İlker Devrim
DOI: 10.46497/ArchRheumatol.2023.9900
Risk of flare in juvenile idiopathic arthritis: Is it related to the methotrexate treatment strategy or patient characteristics?
Rana İşgüder, Zehra Kızıldağ, Rüya Torun, Tuncay Aydın, Balahan Makay, Erbil Ünsal
DOI: 10.46497/ArchRheumatol.2023.10035
Academic publication activities and perspectives of rheumatology practitioners in the COVID-19 pandemic
Abdulvahap Kahveci, Alper Gümüştepe, Nurhan Güven, İsmihan Sunar, Şebnem Ataman
DOI: 10.46497/ArchRheumatol.2023.9957
Three-dimensional kinematics of the trunk, pelvis, hip, and knee during the single-leg squat and hip torque in subjects with isolated patellofemoral osteoarthritis compared to individually matched controls: Preliminary results
Cristiano Carvalho, Fábio Viadanna Serrão, Adalberto Felipe Martinez, Paula Regina Mendes Da Silva Serrão
DOI: 10.46497/ArchRheumatol.2024.9814
Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients
Fatma Yurdakul, Hatice Bodur, Ahmet Kıvanç Cengiz, Yunus Durmaz, Mehmet Tuncay Duruöz, Taciser Kaya, Sertaç Ketenci, Nihan Cüzdan, Tuba Güler, Zafer Günendi, Selda Sarıkaya, Erhan Çapkın, Mustafa Erkut Önder, Meltem Alkan Melikoğlu, Rengin Güzel, Nesrin Şen, Ata Bora Ayna, Özgür Akgül, Erhan Eser, Şebnem Ataman
DOI: 10.46497/ArchRheumatol.2024.10313
Neuropathic component of chronic musculoskeletal pain in patients with post-COVID-19: A cross-sectional study
Sevgi Gümüş Atalay, Pınar Borman, Ayşegül Yaman, Evren Yaşar
DOI: 10.46497/ArchRheumatol.2024.9990
The effect of the pandemic on autoantibody rates in the general population
Mehmet Karabey, Havva Kaya, Alperen Ceylan, Kadir Kaba, Mehmet Özdemir, Bahadır Feyzioğlu
DOI: 10.46497/ArchRheumatol.2024.10330
Common variable immunodeficiency and autoimmune diseases: A 10-year single-center experience
Filiz Sadi Aykan, Fatih Çölkesen, Recep Evcen, Mehmet Kılınç, Eray Yıldız, Şevket Arslan
DOI: 10.46497/ArchRheumatol.2024.10729
Relationship between IgA vasculitis and prothrombotic risk factors: A prospective, case-control study
Cengiz Zeybek, Ahmet Bolat, Orhan Gürsel, Bülent Hacıhamdioğlu, Ahmet Emin Kürekçi
DOI: 10.46497/ArchRheumatol.2024.10711
Predicting extra-musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experience
Elif Durak Ediboglu, Umut Kalyoncu, Dilek Solmaz, Sule Yasar Bilge, Sedat Yılmaz, Cemal Bes, Abdulsamet Erden, Burcu Yagız, Zehra Özsoy, Belkıs Nihan Coskun, Rıdvan Mercan, Sedat Kiraz, Emel Gönüllü, Veli Yazısız, Nilufer Alpay Kanıtez, Askın Ateş, Recep Yılmaz, Hakan Emmungil, Gezmiş Kimyon, Emine Duygu Ersözlü, Süleyman Serdar Koca, İhsan Ertenli, Servet Akar
DOI: 10.46497/ArchRheumatol.2025.10670